share_log

Lake Street Downgrades Silk Road Medical to Hold, Lowers Price Target to $27.5

Lake Street Downgrades Silk Road Medical to Hold, Lowers Price Target to $27.5

Lake Street将silk road medical的评级降为持有,将价格目标下调至$27.5。
Benzinga ·  06/18 17:42

Lake Street analyst Frank Takkinen downgrades Silk Road Medical (NASDAQ:SILK) from Buy to Hold and lowers the price target from $28 to $27.5.

Lake Street分析师Frank Takkinen将Silk Road Medical (纳斯达克:silk road medical)的评级从买入下调至持有,并将价格目标从28美元下调至27.5美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发